Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLA B Leader in Patients With Psoriatic Arthritis
NCT07718815Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- May 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Prevalence of HLA B leader at 1 year. Started May 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07718815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07718815.